The Valley Desk

NCT02627963 · Interventional trial

A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

Overall registry status Completed

Phase 3

Conditions Carcinoma, Renal Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov